Clinical Trials · NCT01656161
Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Debiopharm International SA
- Enrollment
- 120
- Start date
- Jul 2012
- Locations
- 10 sites, South Africa
- Primary endpoint
- Percentage of Participants Achieving and Maintaining Castrate Levels of Serum Testosterone (<1.735 Nmol/L)